The dropless future: SLT as a first-line treatment for glaucoma

Dr. Kristin O. Chapman explains how SLT’s promotion to first-line therapy is changing the age-old battle for glaucoma drop tolerance and adherence.

Read Full Article

Kristin O. Chapman, MD

Explore Other Resources

    PB-00038930 Rev A